Hyderabad to host sickle cell disease congress with delegates from 27 countries
Hyderabad: The city will host an international sickle cell disease congress from October 23 to 25, bringing together around 700 registered delegates from 27 countries. The three-day event will take place at the Hyderabad International Convention Centre (HICC), Novotel, in Madhapur.
The fourth Global Action Network for Sickle Cell and Other Inherited Blood Disorders (GANSID) Congress 2026 will focus on sickle cell disease, thalassemia and related inherited blood disorders.
GANSID CEO Lanre Tunji-Ajayi and Thalassemia and Sickle Cell Society (TSCS) president Dr. Chandrakant Agrawal announced the event on Thursday. They addressed a press conference at the TSCS premises in Shivarampally, Hyderabad.
Sickle cell disease congress to bring delegates from 27 countries
The international gathering is expected to attract medical specialists, researchers, healthcare professionals, policymakers and patient advocacy organisations. Around 700 delegates from 27 countries have registered for the three-day congress.
The discussions will focus on sickle cell disease, thalassemia and other inherited blood disorders. Additionally, the event aims to strengthen international cooperation among healthcare professionals, researchers and organisations working with affected patients.
The congress will also focus on raising awareness about inherited blood disorders and improving healthcare and support systems. The Thalassemia and Sickle Cell Society, Hyderabad, will serve as the local partner for the GANSID Congress 2026.
TSCS is a non-profit organisation that supports more than 4,800 patients affected by thalassemia, sickle cell disease and related conditions. The collaboration seeks to promote cooperation between international organisations and healthcare stakeholders.
Moreover, the organisers aim to improve awareness and strengthen support for patients and their families. The partnership will also bring together professionals and patient advocacy groups involved in inherited blood disorder care.
Healthcare specialists and researchers to participate
The sickle cell disease congress will provide a forum for medical specialists, researchers and policymakers from different countries. Participants will discuss issues concerning inherited blood disorders and the healthcare needs of affected patients.
The organisers also intend to promote cooperation in improving patient care and support systems. Meanwhile, the presence of patient advocacy organisations will bring patient and family concerns into the discussions.
The congress is scheduled to begin on October 23 and conclude on October 25 at HICC in Madhapur. Several TSCS office-bearers attended the press conference announcing the international event.
They included chief medical research officer and secretary Dr. Suman Jain and senior vice-president Ratnavali. Joint secretary Aleem Baig, treasurer Manoj Rupani and Naresh Rathi were also present.
The announcement outlined the participation of international delegates, the congress programme’s focus on inherited blood disorders and TSCS’s role as the local partner.